ClinicalTrials.gg
CompletedNCT05028309Updated Nov 16, 2026

Effects of Obesity in the Aged

An interventional study of Mechanical unloading of the Thorax using an external cuirass in Obesity and Aging, sponsored by University of Texas Southwestern Medical Center. Completed at 1 site in United States. Open to participants aged 65 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by University of Texas Southwestern Medical Center · Not applicable, Interventional, and Other

How we know

Updated Nov 16, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
65 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 31 studies in Obesity by University of Texas Southwestern Medical Center — 6 open to participants now, 7 under way, none of them phase 3. Obesity · University of Texas Southwestern Medical Center.

Enrollment
12th of 24
50 · median 48
Started
2021
with 2 others
No phase
16 of 31
4 open now
Registered
21st of 31
by date

Among the 31 studies in Obesity by University of Texas Southwestern Medical Center, this one is the 12th largest by enrollment of the 24 interventional ones that give a count, is one of 3 that started in 2021, is one of 16 with no phase, and was the 21st registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

6 of the 31 studies in Obesity by University of Texas Southwestern Medical Center are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 65 Years to 75 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 31 studies in Obesity by University of Texas Southwestern Medical Center, or all of them as a file.
02

Study summary

The overall objective of this application is to investigate the effects of obesity on lung function, exercise tolerance, and DOE in older obese adults as compared with older adults without obesity, using a novel probe for mechanically unloading the thorax at rest and during exercise. The investigators will use 1) continuous negative cuirass pressure, and 2) assisted biphasic cuirass ventilation to decrease obesity-related effects in older obese adults. Our approach will be to examine respiratory function, exercise tolerance, and DOE with and without mechanical unloading in older obese men and women (65-75 yr), including those with respiratory symptoms (defined by a score of 1 or 2 on the modified Medical Research Council Dyspnea Scale), as compared with older adults without obesity.

Specific Aims: The investigators will test the following hypotheses in older adults with and without obesity:

Aim 1) Obesity will decrease respiratory function but to a greater extent in older obese adults with respiratory symptoms, (as evidenced by altered pulmonary function and breathing mechanics at rest); Aim 2) Obesity will decrease exercise tolerance (as evidenced by peak V•O2 in ml/min/kg, i.e., physical fitness), but not cardiorespiratory fitness (as evidenced by peak V•O2 in % of predicted based on ideal body wt), except in older obese adults with respiratory symptoms where both may be reduced during graded cycle ergometry.

Aim 3) Obesity will increase DOE but to a greater extent in older obese adults with respiratory symptoms as evidenced by increased ratings of perceived breathlessness (sensory \& affective dimensions) during exercise.

Aim 4) Mechanical unloading of the thorax will improve respiratory function, submaximal exercise tolerance, and DOE in older obese adults, but to a greater extent in older obese adults with respiratory symptoms.

Read the detailed description

Over 40% of older adults (60+ yr) are obese and 30% are overweight. While regular exercise is an important component in the prevention and treatment of obesity, many older adults with obesity are unable or unwilling to exercise due to exercise intolerance and/or dyspnea on exertion (DOE). The Investigators have identified numerous obesity-related respiratory effects that could influence exercise tolerance and DOE in younger obese adults including decreased pulmonary function altered respiratory mechanics increased work of breathing and increased metabolic demands of exercise. The Investigators have also identified many age-related ventilatory constraints in older adults without obesity. However, it is unclear whether these obesity-related and aging-related effects combine to reduce exercise tolerance, impose DOE, or contribute to respiratory symptoms in older obese adults. Respiratory symptoms in older adults are often wrongly diagnosed as deconditioning and/or cardiopulmonary disease, placing older obese adults at risk of costly clinical testing, unnecessary treatment, and potentially a reluctance to exercise, which is counterproductive to weight loss (WL) and the preservation of functional capacity, thus further diminishing their quality of life. The respiratory effects of obesity are underappreciated and have not been carefully examined in older adults, especially older obese adults with "respiratory symptoms" who may experience even greater respiratory effects.

The Investigators propose that many of the obesity-related respiratory effects in older obese adults are the result of low lung volume breathing, i.e., a reduction in functional residual capacity (FRC) at rest (seated upright \& supine), and end-expiratory lung volume (EELV) during exercise. The Investigators suggest that increased fat on the chest wall (i.e., abdomen \& rib cage) produces low FRC and EELV levels, where breathing limitations like expiratory flow limitation and enhanced perception of dyspnea are more likely to occur. This is because older adults have an age-related decline in maximal expiratory flow at low lung volumes. As such, excess fat on the thorax appears to exert an unfavorable burden on the older obese adult, particularly during exercise. Our overall hypothesis is that respiratory limitations, exercise intolerance, DOE, and respiratory symptoms in older obese adults are due to mechanical loading of the thorax and low lung volume breathing coupled with the age-related decline in maximal expiratory flow. The Investigators propose to test this hypothesis with the use of an external cuirass (i.e., a plastic shell over the thorax) to mechanically unload the chest wall.

Although our laboratory has used modest WL in younger obese women to reduce the effects of obesity, the mechanisms by which WL (i.e., decreased fat over the entire body) decreases DOE remain unclear. This may be in part due to our single global assessment of DOE (i.e., sensory domain only \& pre-post WL only), and/or that changes in DOE in the time domain are not in parallel with WL. To circumvent these limitations of WL, an external cuirass will be used to mechanically unload the chest wall (includes rib cage \& abdomen) in older obese adults. This will effectively decrease the load on the chest wall thereby increasing FRC at rest and EELV during exercise (i.e., via continuous negative cuirass pressure), and potentially decreasing the work of breathing during exercise (i.e., via assisted biphasic cuirass ventilation). This novel and quantifiable probe will allow us to investigate the effects of obesity in older adults and their influence on lung function, exercise tolerance, and DOE (sensory \& affective dimensions). The proposed mechanistic studies would lead to a better understanding of the mechanical effects of obesity in older adults, which could alter testing and treatment strategies for older obese adults, especially those with exercise intolerance, DOE, and respiratory symptoms.

The overall objective of this application is to investigate the effects of obesity on lung function, exercise tolerance, and DOE in older obese adults as compared with older adults without obesity, using a novel probe for mechanically unloading the thorax at rest and during exercise. The Investigators will use 1) continuous negative cuirass pressure, and 2) assisted biphasic cuirass ventilation to decrease obesity-related effects in older obese adults. Our approach will be to examine respiratory function, exercise tolerance, and DOE with and without mechanical unloading in older obese men and women (65-75 yr), including those with respiratory symptoms (defined by a score of 1 or 2 on the modified Medical Research Council Dyspnea Scale), as compared with older adults without obesity.

Specific Aims: The Investigators will test the following hypotheses in older adults with and without obesity:

Aim 1) Obesity will decrease respiratory function but to a greater extent in older obese adults with respiratory symptoms, (as evidenced by altered pulmonary function and breathing mechanics at rest); Aim 2) Obesity will decrease exercise tolerance (as evidenced by peak V•O2 in ml/min/kg, i.e., physical fitness), but not cardiorespiratory fitness (as evidenced by peak V•O2 in % of predicted based on ideal body wt), except in older obese adults with respiratory symptoms where both may be reduced during graded cycle ergometry.

Aim 3) Obesity will increase DOE but to a greater extent in older obese adults with respiratory symptoms as evidenced by increased ratings of perceived breathlessness (sensory \& affective dimensions) during exercise.

Aim 4) Mechanical unloading of the thorax will improve respiratory function, submaximal exercise tolerance, and DOE in older obese adults, but to a greater extent in older obese adults with respiratory symptoms.

The investigators' long-term objective is to examine the effects of obesity in older obese adults and provide novel results that could clarify the mechanisms of respiratory limitations, exercise intolerance, DOE, and/or obesity-related respiratory symptoms in older obese adults. Thus, these results will have broad and immediate clinical impact on the care of older adults with obesity, especially those with exercise intolerance, DOE, and/or respiratory symptoms.

03

Conditions studied

  • Obesity
  • Aging

Browse trials for

04

Who can participate

Ages eligible
65 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Otherwise healthy older adults 65-75 years of age with normal lung function; men 30\< %body fat ≤50 and women 35\< %body fat ≤55; and ability to perform pulmonary and exercise test. Other inclusion criteria include the following:
  • Nonsmokers who have no history of smoking
  • No personal history of significant mental illness
  • No weight loss dietary restrictions
  • No current or past history of significant substance or alcohol abuse
  • No history, evidence, or uncontrolled symptoms of heart disease
  • No history of uncontrolled hypertension
  • No current medications that may interfere with exercise capacity
  • No recent history or indication of asthma
  • No musculoskeletal abnormality that would preclude exercise
  • No serious health conditions that would preclude study goals or participation in exercise (per PI \& medical staff \& preliminary or follow up testing; including significant other diseases, occult asthma, prior surgeries-especial lung or abdominal, or history of chemotherapy that could affect lung or heart function)
  • Only women will be included.
  • Women on hormone replacement therapy will be allowed to participate if the dosage remains similar during the entire protocol.

Exclusion criteria

Exclusion Criteria:

  • Volunteers with a mMRC score of 3 or 4 will be excluded due to likeliness of underlying disease.
  • Individuals participating in regular vigorous conditioning exercise such as running, jogging, aerobics, cycling, or swimming more than three times per week will be excluded. However, if subjects have an exceedingly high exercise capacity (greater than 2 SD of predicted), they will be excluded.
  • Maximal cycle ergometry test will be used to determine if further participation in testing is appropriate for the participant (e.g., normal exercise test, exclude presence of provokable changes suggestive of heart disease, or dangerous arrhythmias or exercise induced hypertension or bronchoconstriction. If the participant develops an abnormal ECG or shows other signs of exercise intolerance or if signs of cardiovascular disease are noted during the exercise test, it will be terminated and the participant will be referred to their personal physician for further evaluation (see DMSP).
  • Premenopausal women will be excluded.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

ECG (electrocardiogram)

A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Interventional Arm

    Older group of adults (65-75 yrs). Everyone enrolled uses the 'intervention'/ external cuirass - mechanical unloading of thorax

    Other: Mechanical unloading of the Thorax using an external cuirass

Interventions

  • OtherMechanical unloading of the Thorax using an external cuirass

    External cuirass (i.e., a plastic shell over the thorax) will be used to mechanically unload the chest wall. The cuirass has different operating modes. It can generate a constant negative pressure over the chest wall (e.g., -20cmH2O) or it can be triggered off mouth flow so it can generate a negative pressure on the chest wall during inspiration (e.g., -21cmH2O) and a positive pressure during expiration (e.g., +7cmH2O).

06

What researchers measure

Primary outcomes

  1. Change in Pulmonary Function: Lung Volumes

    Pulmonary function is comprised of several physiological variables but this study will primarily measure Lung Volume: FRC (liters) and TLC (liters)

    Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic)

  2. Change in Exercise Tolerance - Peak VO2

    Exercise Tolerance is represented by several physiological variables but the primary variable is Maximal oxygen uptake (L/min and percent predicted)

    Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic).

  3. Change in Dyspnea on Exertion

    Dyspnea on Exertion is represented using the Borg Scale which provides Ratings of Perceived Breathlessness (RPB) during constant load exercise cycling. The Borg Scale measures from 0-10, where 0 = no breathlessness and 10 = maximal breathlessness.

    Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic).

  4. Changes in PANAS Questionnaire

    Positive and Negative Affect Schedule. This scale consists of a number of words that describe different feelings and emotions.

    Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic).

  5. Modified Medical Research Council Dyspnea Scale (mMRC Dyspnea Scale)

    Investigate the qualities of respiratory sensations (e.g., "effort of breathing", "breathing heavy", "breathing shallow") during exercise before and after mechanical unloading of the chest wall

    Time frame: Outcome measures will be assessed immediately after completion of mMRC questionnaire (during study visit 2)

  6. Dyspnoea-12

    This questionnaire is designed to help us learn more about how their breathing is troubling them.

    Time frame: Outcome measures will be assessed immediately after completion of Dyspnoea-12 questionnaire (during study visit 2)

  7. ASI

    The Anxiety Sensitivity Index (ASI) is a 16 item scale containing items specifying different concerns someone could have regarding their anxiety.

    Time frame: Outcome measures will be assessed immediately after completion of ASI questionnaire (during study visit 2)

  8. HADS

    HADS (Hospital Anxiety and Depression Scale) aims to measure symptoms of anxiety (HADS Anxiety) and depression (HADS Depression). HADS score: 0-7 = normal; 8-10 = mild; 11-14 = moderate; 15-21 = severe

    Time frame: Outcome measures will be assessed immediately after completion of HADS questionnaire (during study visit 2)

  9. SDS-MC

    The Marlowe-Crowne Social Desirability Scale (MC-SDS) is a 33-item self-report questionnaire that assesses whether or not respondents are concerned with social approval.

    Time frame: Outcome measures will be assessed immediately after completion of MC-SDS questionnaire (during study visit 2)

  10. IPAQ

    International Physical Activity Questionnaires (IPAQ) is a 27-item self-reported measure of physical activity

    Time frame: Outcome measures will be assessed immediately after completion of IPAQ questionnaire (during study visit 2)

  11. WSQ

    Workforce Sitting Questionnaire (WSQ) is to estimate how much time they usually spend sitting in each of the following activities on a working day and a non-working day.

    Time frame: Outcome measures will be assessed immediately after completion of WSQ questionnaire (during study visit 2)

  12. SF-12

    SF-12 is a health-related quality-of-life questionnaire

    Time frame: Outcome measures will be assessed immediately after completion of SF-12 questionnaire (during study visit 2)

Secondary outcomes

  1. Changes in forced vital capacity (FVC)

    FVC is the total amount of air (liters) exhaled during the forced expiratory volume (FEV) lung function test during spirometry.

    Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic)

  2. Changes in forced expiratory volume (FEV)

    FEV is the amount of air (liters) a person can exhale during a forced breath. The amount of air exhaled is measured during the a lung function test during spirometry.

    Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic)

  3. Changes in forced expiratory volume in 1 second (FEV1)

    FEV1 is the maximum amount of air (liters) that the a participant can forcibly expel during the first second following maximal inhalation. The FEV1 is measured during the a lung function test during spirometry.

    Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic)

  4. Changes in FEV1/FVC Ratio

    The FEV1/FVC (%) ratio is a calculation often used to determine the presence of obstructive or restrictive lung diseases such as chronic obstructive pulmonary disease (COPD).

    Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic)

  5. Changes is peak flow

    Peak flow measurement is done with a peak flow meter. It measures the maximum (or peak) speed at which air (liters/sec) can be blown out of the lungs. This measurement provides a general idea of how narrow the lung airways are. It can also show how much the airways are changing over time if measured each day.

    Time frame: ChangesOutcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic) between conditions (visits 3-6) compared to baseline between cohorts

  6. Pulmonary Function: Diffusing Capacity

    Diffusing Capacity: Diffusing capacity of lung for carbon monoxide(DLco) (ml/mmHg/min)

    Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic)

  7. Exercise Tolerance: Work Rate

    Associated variables such as work rate (W)

    Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic)

  8. Exercise Tolerance: Minute Ventilation

    Associated variables such as pulmonary ventilation (L/min)

    Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic)

  9. Exercise Tolerance: Operational Lung Volumes

    Associated variables such as operational lung volumes (EELV and EILV as a % of TLC)

    Time frame: Outcome measures will be assessed within 24-48hrs after completion of each study condition (baseline, control, continuous, and dynamic)

07

Study locations

1 site
  • Institute for Exercise and Environmental Medicine, UT Southwestern and Texas Health Resources
    Dallas, Texas 75231, United States
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2021 to primary completion in Jul 2025, 43 months.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 43 months is above that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: primary completion Dec 2026 → Jul 2025 and completion Dec 2026 → Jul 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 17, 2021
First posted
Aug 31, 2021
StartActual
Dec 1, 2021
Primary completionActual
Jul 31, 2025was Dec 2026
CompletionActual
Jul 31, 2026was Dec 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 16, 2026
Primary completion
Dec 31, 2026→Jul 31, 2025 (actual)
Nov 16, 2026
Study completion
Dec 31, 2026→Jul 31, 2026 (actual)
Nov 16, 2026
Enrollment
72 (estimated)→50 (actual)
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Recruiting→Completed
    Primary completion Dec 31, 2026→Jul 31, 2025 (now actual)
    Study completion Dec 31, 2026→Jul 31, 2026 (now actual)
    Enrollment 72 (estimated)→50 (actual)
    + 3 other changes: design details, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT05028309
Responsible party
Tony Babb (PROFESSOR, Cardiopulmonary Laboratory Director, Effie and Wofford Cain Chair in Cardiopulmonary Research, Institute of Exercise and Environmental Medicine, Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center) — Principal investigator
First posted
Aug 31, 2021
Start date
Dec 1, 2021
Primary completion
Jul 31, 2025
Completion
Jul 31, 2026
Last update
Nov 16, 2026

Study contacts

Tony G Babb, Ph.D.
principal investigator · University of Texas Southwestern Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion